Dependency of kidney function decline on intensive clinic blood pressure lowering in patients with high arterial stiffness: a post-hoc analysis of a randomized controlled trial
American Journal of Hypertension · 01.12.2026 · 39 (12) · 1389-1396
DOI: 10.1093/ajh/hpag088 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift American Journal of Hypertension, online erschienen am 17.07.2026. Verfasst von Ying Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Shanghai Institute of Hypertension, National Center for Translational Medicine · Shanghai, State Key Laborator…. Hauptthemen laut MEDLINE: Acute Kidney Injury, Antihypertensive Agents, Blood Pressure, Calcium Channel Blockers. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Beijing BaiMeiTe Pharmaceuticals Co., Ltd.
Abstract (Originalsprache)
Background
Intensive blood pressure (BP) lowering increases acute kidney injury risk, despite cardiovascular benefits. We investigated the association between treatment-induced BP changes and kidney function decline, while accounting for arterial stiffness.
Methods
This post-hoc analysis included 266 patients with hypertension from a 20‑week double‑blind trial treated with calcium-channel blockers. Kidney dysfunction was defined as an estimated glomerular filtration rate (eGFR) <60 mL/minute·1.73 m2 or a decrease ≥30% from baseline. Arterial stiffness was measured as brachial-ankle pulse wave velocity (baPWV).
Results
At baseline, systolic/diastolic BP (mean ± SD, 153.2 ± 9.3/91.8 ± 9.5 mm Hg) was associated positively (r = 0.20 [95% CI, 0.09 to 0.32]/0.23 [95% CI, 0.11 to 0.34]) with serum creatinine (72.1 ± 16.2 μmol/L), and inversely (r = −0.25 [95% CI, −0.36 to −0.14]/−0.16 [95% CI, −0.28 to −0.04]) with eGFR (91.6 ± 13.8 mL/minute·1.73 m2). The associations with clinic systolic BP were weakened with higher baPWV, being observed in tertiles 1 and 2 (r ≥ 0.30 or ≤−0.27), but not in tertile 3. After 20 weeks of treatment, the incidence of kidney dysfunction was 0%, 4.8%, and 6.4%, respectively, in tertiles 1, 2, and 3 of baPWV (odds ratio for tertile 3 vs tertile 1, 2.23 [95% CI, 0.84-5.95]). In longitudinal analysis, the least squares mean change from baseline in eGFR was −3.7 mL/minute·1.73 m2 (95% CI, −4.3 to 1.1) in patients within tertile 3 of both baseline baPWV and treatment-induced clinic systolic BP changes.
Conclusions
In patients with stiffer arteries, kidney function at baseline was not associated with higher BP, and its decline during follow-up was greater when clinic BP was intensively reduced.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Shanghai Institute of Hypertension, National Center for Translational Medicine · Shanghai, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Ruijin…
ORCID-Profile: Ying Wang, Yan Li, Ji-Guang Wang
Förderung
- Beijing BaiMeiTe Pharmaceuticals Co., Ltd
Zitieren
APA
Wang, Y., Li, Y., & Wang, J. G. (2026). Dependency of kidney function decline on intensive clinic blood pressure lowering in patients with high arterial stiffness: a post-hoc analysis of a randomized controlled trial. American Journal of Hypertension, 39(12), 1389-1396. https://doi.org/10.1093/ajh/hpag088
Vancouver
Wang Y, Li Y, Wang JG. Dependency of kidney function decline on intensive clinic blood pressure lowering in patients with high arterial stiffness: a post-hoc analysis of a randomized controlled trial. American Journal of Hypertension. 2026;39(12):1389-1396. doi:10.1093/ajh/hpag088
BibTeX
@article{Wang2026,
author = {Wang, Ying and Li, Yan and Wang, Ji-Guang},
title = {Dependency of kidney function decline on intensive clinic blood pressure lowering in patients with high arterial stiffness: a post-hoc analysis of a randomized controlled trial},
journal = {American Journal of Hypertension},
year = {2026},
volume = {39},
number = {12},
pages = {1389--1396},
doi = {10.1093/ajh/hpag088}
}
EUVIMED